Cancer Immunology and Immunotherapy
The PhD Program in Cancer Immunology and Immunotherapy at Moffitt provides an enriched educational environment by blending advanced studies in fundamental cancer immunology and novel immunotherapies. The program fosters interdisciplinary research through collaborations with experts in immunology, oncology, molecular biology, metabolism, bioengineering, bioinformatics and translational medicine.
Guided by faculty with strong records of high-impact research, students gain practical experience in state-of-the-art lab and clinical settings. Unique to this program is its focus on integrated translational research opportunities, enabling a seamless transition from innovative laboratory discoveries to clinical applications. This integrated approach uniquely equips graduates to contribute to advancements in both fundamental immunology and translational immune therapy against cancer.
Moffitt Cancer Center is a designated Comprehensive Cancer Center by the National Cancer Institute (NCI), signifying the highest level of recognition in cancer research and treatment. This designation underscores Moffitt's excellence in various aspects such as fundamental and clinical research, prevention, education, outreach and patient care.
For more information, contact the Program Coordinator at CancerPhD@moffitt.org.
Cancer Immunology and Immunotherapy PhD